|
1
|
Leyendecker G, Kunz G, Noe M, Herbertz M
and Mall G: Endometriosis: A dysfunction and disease of the
archimetra. Hum Reprod Update. 4:752–762. 2015. View Article : Google Scholar
|
|
2
|
Vercellini P, Viganò P, Somigliana E and
Fedele L: Endometriosis: Pathogenesis and treatment. Nat Rev
Endocrinol. 10:261–275. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gaudillère A, Misery L, Bernard C,
Souchier C, Claudy A and Schmitt D: Presence of somatostatin in
normal human epidermis. Br J Dermatol. 137:376–380. 2015.
View Article : Google Scholar
|
|
4
|
Modlin IM, Pavel M, Kidd M and Gustafsson
BI: Review article: Somatostatin analogues in the treatment of
gastroenteropancreatic neuroendocrine (carcinoid) tumours. Aliment
Pharmacol Ther. 31:169–188. 2010.PubMed/NCBI
|
|
5
|
Appetecchia M and Baldelli R: Somatostatin
analogues in the treatment of gastroenteropancreatic neuroendocrine
tumours, current aspects and new perspectives. J Exp Clin Cancer
Res. 29:192010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pollak MN and Schally AV: Mechanisms of
antineoplastic action of somatostatin analogs. Proc Soc Exp Biol
Med. 217:143–152. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fanselow EE and Connors BW: The roles of
somatostatin-expressing (GIN) and fast-spiking inhibitory
interneurons in up-down states of mouse neocortex. J Neurophysiol.
104:596–606. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ludlam WH and Anthony L: Safety review:
Dose optimization of somatostatin analogs in patients with
acromegaly and neuroendocrine tumors. Adv Ther. 28:825–841. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Igarashi H, Hijioka M, Lee L and Ito T:
Biotherapy of pancreatic neuroendocrine tumors using somatostatin
analogs. J Hepatobiliary Pancreat Sci. 22:618–622. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Samimi M, Gardair C, Touze A, Coursagetb
P, Kerdraond R, Estevee E, Crouef A, Avenel-Audrang M, Hainaulth E,
Benetoni N, et al: Expression des récepteurs de la somatostatine
(SSTR-2A et SSTR-5) et relation avec les données cliniques dans une
cohorte de 99 patients avec carcinomes à cellules de Merkel.
Annales De Dermatologie Et De Venereologie. 141:S242–S243. 2014.
View Article : Google Scholar
|
|
11
|
Kaemmerer D, Schindler R, Mußbach F,
Dahmen U, Altendorf-Hofmann A, Dirsch O, Sänger J, Schulz S and
Lupp A: Somatostatin and CXCR4 chemokine receptor expression in
hepatocellular and cholangiocellular carcinomas: Tumor capillaries
as promising targets. BMC Cancer. 17:8962017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Halmos G, Sun B, Schally AV, Hebert F and
Nagy A: RAPID COMMUNICATION: Human ovarian cancers express
somatostatin receptors. J Clin Endocrinol Metabol. 85:3509–3512.
2000. View Article : Google Scholar
|
|
13
|
Green VL, Richmond I, Maguiness S,
Robinson J, Helboe L, Adams IP, Drummond NS and Atkin SL:
Somatostatin receptor 2 expression in the human endometrium through
the menstrual cycle. Clin Endocrinol (Oxf). 56:609–614. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boujenah J, Hugues JN, Sifer C, Bricou A,
Cédrin-Durnerin I, Sonigo C, Monforte M and Poncelet C:
Endometriosis fertility index, or classification of the american
society of reproductive medicine for postoperative endometriosis
patients with infertility: Which is more relevant? Gynecol Obstet
Fertilite. 43:806–809. 2015.(In French). View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Szolcsányi J, Helyes Z, Oroszi G, Németh J
and Pintér E: Release of somatostatin and its role in the mediation
of the anti-inflammatory effect induced by antidromic stimulation
of sensory fibres of rat sciatic nerve. Br J Pharmacol.
123:936–942. 2010. View Article : Google Scholar
|
|
17
|
Nilsson CL, Brinkmalm A, Minthon L,
Blennow K and Ekman R: Processing of neuropeptide Y, galanin and
somatostatin in the cerebrospinal fluid of patients with Alzheimers
disease and frontotemporal dementia. Peptides. 22:2105–2112. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang TC, Park SK, Do SG, Suh JG, Jo SM, Oh
YS, Jeong YG and Won MH: The over-expression of somatostatin in
gerbil entorhinal cortex induced by seizure. Brain Res. 882:55–61.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patel YC: Somtostat in and its receptor
family. Front Neuroendocrinol. 20:157–198. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sbracia M and Scarpellini F: PIF
expression in endometriosis: Its possible role in inducing ectopic
endometrium immune-privilege. J Reprod Immunol. 122:402017.Ho HN,
Wu MY and Yang YS: Peritoneal cellular immunity and endometriosis.
Am J Reprod Immunol 38: 400.412, 2011. View Article : Google Scholar
|
|
21
|
Lang J: Further improve EMS basic and
clinical research. Chin J Obstet Gynecol. 36:711–713. 2001.(In
Chinese).
|
|
22
|
Scarborough DE, Lee SL, Dinarello CA and
Reichlin S: Interleukin-1 beta stimulates somatostatin biosynthesis
in primary cultures of fetal rat brain. Endocrinology. 124:549–551.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dasgupta P: Somatostatin an alogues:
Multiple roles incellular proliferation, neoplasia,
andangiogenesis. Pharmacol Ther. 102:61–85. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma W, Liu B, Li Y, Huang ZJ, Zhang LI and
Tao HW: Visual representations by cortical somatostatin inhibitory
neurons-selective but with weak and delayed responses. J Neurosci.
30:14371–14379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reisine T and Bell GI: Molecular
properties of somatostatin receptor. Neuroscience. 67:777–790.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cordelier P, Estève JP, Bousquet C,
Delesque N, O'Carroll AM, Schally AV, Vaysse N, Susini C and
Buscail L: Characterization of the antiproliferative signal
meditated by the somatostatin receptor subtype SSTR5. Proc Natl
Acad Sci USA. 94:9343–9348. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Charland S, Boucher MJ, Houde M and Rivard
N: Somatostatin inhibits Aktphosphorylation and cell cycle entry,
but not p42/p 44 mitogen activated protein(MAP)kinase activation in
normal and tumoral pancreatic acinar cells. Endocrinology.
142:121–128. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Feooux G, Bousquet C, Cordelier P, Benali
N, Lopez F, Rochaix P, Buscail L and Susini C: Signal transduction
of somatostatin receptors negatively controlling cell
proliferation. J Physiol Paris. 94:205–210. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Feuoux G, Lopez E, Esteve JP, Ferrand A,
Vivier E, Vely F, Saint-Laurent N, Pradayrol L, Buscail L and
Susini C: Critical role of Src and SHP-2 in sst2 somatostatin
receptor-mediated activation of SHP-1 and inhibition of cell
proliferation. Mol Biol Cell. 14:3911–3928. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Woltering EA: Development of targeted
somatostatin-based antiangiogenic therapy: A review and future
perspectives. Cancer Biother Radiopharm. 18:601–609. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Adams RL, Adams IP, Lindow SW, Zhong W and
Atkin SL: Somatostatin receptors 2 and 5 are preferentially
expressed in proliferating endothelium. Br J Cancer. 92:1493–1498.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Y, Cao H, Hu YY, Wang H and Zhang
CJ: Inhibitory effect of curcumin on angiogenesis in ectopic
endometrium of rats with experimental endometriosis. Int J Mol Med.
27:87–94. 2011.PubMed/NCBI
|
|
33
|
Ferone D, Lombardi G and Colao A:
Somatostatin receptors inimmune system cells. Minerva Endocrinol.
26:165–173. 2001.(In Italian). PubMed/NCBI
|
|
34
|
Mehta S, de Reuver PR, Gill P, Andrici J,
D'Urso L, Mittal A, Pavlakis N, Clarke S, Samra JS and Gill AJ:
Somatostatin receptor SSTR-2a expression is a stronger predictor
for survival Than Ki-67 in pancreatic neuroendocrine tumors.
Medicine (Baltimore). 94:e12812015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Krenning EP, Kooij PP, Pauwels S, Breeman
WA, Postema PT, De Herder WW, Valkema R and Kwekkeboom DJ:
Somatostatin receptor: Scintigraphy and radionuclide therapy.
Digestion. 57 Suppl 1:S57–S61. 1996. View Article : Google Scholar
|
|
36
|
van Eijck CH, Krenning EP, Bootsma A, Oei
HY, van Pel R, Lindemans J, Jeekel J, Reubi JC and Lamberts SW:
Somatostatin-receptor scintigraphy in primary breast cancer.
Lancet. 343:640–643. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Reynaert H, Rombouts K, Vandermonde A,
Urbain D, Kumar U, Bioulac-Sage P, Pinzani M, Rosenbaum J and
Geerts A: Expression of somatostatin receptors in normal and
cirrhotic human liver and in hepatocellular carcinoma. Gut.
53:1180–1189. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hansson J, Bjartell A, Gadaleanu V, Dizeyi
N and Abrahamsson PA: Expression of somatostatin receptor subtypes
2 and 4 in human benign prostatic hyperplasia and prostatic cancer.
Prostate. 53:50–59. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li M, Li W, Kim HJ, Yao Q, Chen C and
Fisher WE: Characterization of somatostatin receptor expression in
human pancreatic cancer using real-time RT-PCR. J Surg Res.
119:130–137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Raderer M, Traub T, Formanek M, Virgolini
I, Osterreicher C, Fiebiger W, Penz M, Jäger U, Pont J, Chott A and
Kurtaran A: Somatostatin-receptor scintigraphy for staging and
follow-up of patients with extraintestinal marginal zone B-cell
lymphoma of the mucosa associated lymphoid tissue(MALT)-type. Br J
Cancer. 85:1462–1466. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schulz S, Schmitt J and Weise W: Frequent
expression of immunoreactive somatostatin receptors in cervical and
endometrial cancer. Gynecol Oncol. 89:385–390. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fasciani A, Quilici P, Biscaldi E, Flamini
M, Fioravanti A, Orlandi P, Oliviero J, Repetti F, Bandelloni R,
Danesi R, et al: Overexpression and functional relevance of
somatostatin receptor-1, −2, and −5 in endometrium and
endometriotic lesions. J Clin Endocrinol Metab. 95:5315–5319. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Annunziata M, Luque RM, Durán-Prado M,
Baragli A, Grande C, Volante M, Gahete MD, Deltetto F, Camanni M,
Ghigo E, et al: Somatostatin and somatostatin analogues reduce
PDGF-induced endometrial cell proliferation and motility. Hum
Reprod. 27:2117–2129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kumar S, Mishra Kumar A, Chhikara BS,
Chuttani K and Sharma Kumar R: Preparation and pharmacological
evaluation of a new radiopharmaceutical,
technetium-99m-5-fluorouracil, for tumor scintigraphy. Hell J Nucl
Med. 11:91–95. 2008.PubMed/NCBI
|
|
45
|
Hasegawa S, Kobayashi N, Tokuhisa M, Goto
A, Takano S, Takada Y, Kaneta T, Mori R, Matsuyama R, Endo I, et
al: Clinical usefulness of somatostatin receptor scintigraphy in
Japanese patients with gastroenteropancreatic neuroendocrine
tumors. Digestion. 96:132017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kennedy SH, Mojiminiyi OA, Soper N,
Shepstone BJ and Barlow DH: Immunoscintigraphy of endometriosis. Br
J Obstet Gynecol. 97:667–670. 2010. View Article : Google Scholar
|
|
47
|
Rochaix P, Delesque N, Estève JP,
Saint-Laurent N, Voight JJ, Vaysse N, Susini C and Buscail L: Gene
therapy for pancreatic carcinoma: Local and distant antittmaor
effects after somatostatin receptor sst2 gene transfer. Human Gene
Therapy. 10:995–1008. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chaudhuri TR, Rogers BE, Buchsbaum DJ,
Mountz JM and Zinn KR: A noninvasive receptor system to image
Adenoviral-mediated gene transfer to ovarian cancer xenogragts.
Gynecol Oncol. 83:432–438. 2001. View Article : Google Scholar : PubMed/NCBI
|
